EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

GPR119 expression in normal human tissues and islet cell tumors: evidence for its islet-gastrointestinal distribution, expression in pancreatic beta and alpha cells, and involvement in islet function



GPR119 expression in normal human tissues and islet cell tumors: evidence for its islet-gastrointestinal distribution, expression in pancreatic beta and alpha cells, and involvement in islet function



Metabolism: Clinical and Experimental 62(1): 70-78



GPR119 is reportedly involved in regulating glucose metabolism and food intake in rodents, but little is known about its expression and functional significance in humans. To begin to assess the potential clinical importance of GPR119, the distribution of GPR119 gene expression in humans was examined. Expression of GPR119 mRNA in fresh samples of normal human pancreas (n=19) and pancreatic islets (n=3) and in insulinomas (n=2) and glucagonomas (n=2), all collected at surgery, was compared with the mRNA expression of various receptors highly expressed and operative in human pancreatic islets. GPR119 mRNA was most abundant in the pancreas, followed by the duodenum, stomach, jejunum, ileum and colon. Pancreatic levels of GPR119 mRNA were similar to those of GPR40 mRNA and were higher than those of GLP1R and SUR1 mRNA, which are strongly expressed in human pancreatic islets. Moreover, levels of GPR119 mRNA in pancreatic islets were more than 10 times higher than in adjacent pancreatic tissue, as were levels of GPR40 mRNA. GPR119 mRNA was also abundant in two cases of insulinoma and two cases of glucagonoma, but was undetectable in a pancreatic acinar cell tumor. Similar results were obtained with mouse pancreatic islets, MIN6 insulinoma cells and alpha-TC glucagonoma cells. The results provide evidence of an islet-gastrointestinal distribution of GPR119, its expression in pancreatic beta and alpha cells, and its possible involvement in islet function. They also provide the basis for a better understanding of the potential clinical importance of GPR119.

(PDF emailed within 0-6 h: $19.90)

Accession: 053342847

Download citation: RISBibTeXText

PMID: 22883930

DOI: 10.1016/j.metabol.2012.06.010



Related references

Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 47(2): 225-239, 2004

Persistent expression of HNF6 in islet endocrine cells causes disrupted islet architecture and loss of beta cell function. Development 127(13): 2883-2895, 2000

Stable alpha- and beta-islet cell function after tolerance induction to pancreatic islet allografts in diabetic primates. American Journal of Transplantation 3(2): 128-138, 2003

Impairment of pancreatic islet beta cell function induced by intermittent high glucose through oxidative and endoplasmic reticulum stress: experiment with rat pancreatic islet beta cells. Zhonghua Yi Xue Za Zhi 88(28): 2002-2004, 2008

Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proceedings of the National Academy of Sciences of the United States of America, 93(8): 3492-3496, 1996

Expression of islet amyloid polypeptide in fetal and adult porcine and human pancreatic islet cells. Endocrinology 138(4): 5319-5325, 1997

Expression of islet amyloid polypeptide in fetal and adult porcine and human pancreatic islet cells. Endocrinology 137(12): 5319-5325, 1996

Endothelial progenitor cells enhance islet engraftment, influence β-cell function, and modulate islet connexin 36 expression. Cell Transplantation 24(1): 37-48, 2015

Expression of human Fas ligand on mouse beta islet cells does not induce insulitis but is insufficient to confer immune privilege for islet grafts. Journal of Biomedical Science 8(3): 262-269, May-June, 2001

Differential expression of rat pancreatic islet Beta-cell glucose transporter (GLUT 2), proinsulin and islet amyloid polypeptide genes after prolonged fasting, insulin-induced hypoglycaemia and dexamethasone treatment. Diabetologia 35(12): 1125-1132, 1992

Neuropilin-2 is a novel neuroendocrine marker expressed in pancreatic islet cells and islet cell tumors. Laboratory Investigation 81(1): 202A, January, 2001

Immunocytochemical localization of prohormone convertase 1/3 and 2 in pancreatic islet cells and islet cell tumors. Pancreas 23(2): 172-176, 2001

Purified Human Pancreatic Islet: Viability Estimation of Islet Using Fluorescent Dyes, Attachment II, Islet Viability Worksheet: Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium. Cellr4-- Repair, Replacement, Regeneration, & Reprogramming 3(1), 2019

Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons. Proceedings of the National Academy of Sciences of the United States of America 106(33): 13992-7, 2009

Protection of pancreatic beta-cells during islet isolation and assessment of islet viability and candidate diabetes drugs after islet isolation. Official Gazette of the United States Patent & Trademark Office Patents 1256(4), Mar 26, 2002